Responsive image

Drug Information

Drug Generic Name hexa Combined Diphtheria-Tetanus-acellular Pertussis (DTPa), Hepatitis B, Inactivated Poliovirus and Haemophilus influenzae type b Vaccine
Drug Class VACCINES
Chapter Immunological Products & Vaccines

Indications: Active primary immunization against six diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio) and Haemophilus influenzae type b (Hib).

Contra-indications: Active or acute infection, concomitant corticosteroid therapy, immunosuppressive therapy, history of hypersensitivity; brain disease or central nervous system (CNS) disease (i.e. Epilepsy etc.); a bleeding problem; a tendency to febrile convulsions; a family history of seizures/fits; a family history of Sudden Infant Death Syndrome (SIDS).

Side Effects: Mild effects- pain, redness, swelling, a hard lump, bruising or itching around the injection site. fever between 38 °C and 39.5 °C. unusual crying (for more than 1 hour), vomiting, diarrhoea, runny nose or loss of appetite sleepiness, nervousness, irritability restlessness, fussiness or difficulty sleeping. skin rash, bruising, or purple or red-brown spots visible through the skin (purpura). MORE serious effects: fever greater than 39.5°C; crying for 3 hours or more; collapse or periods of unconsciousness or lack of awareness. seizures (convulsions) or fits.

Dose: For primary immunization: three doses of 0.5 ml are given at 2, 4 and 6 months of age.

All doses are IM

Brand Name
  • Infanrix
rating - 1 starrating - 2 starrating - 3 starrating - 4 starrating - 5 star